25C-NBOMe
Selected indexed studies
- 25C-NBOMe Ingestion. (Clin Pract Cases Emerg Med, 2017) [PMID:29849316]
- 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. (Biomed Res Int, 2014) [PMID:25105138]
- 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro. (Neurotox Res, 2019) [PMID:30806983]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- 25C-NBOMe Ingestion. (2017) pubmed
- 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. (2014) pubmed
- 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro. (2019) pubmed
- Death after 25C-NBOMe and 25H-NBOMe consumption. (2017) pubmed
- Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper. (2015) pubmed
- Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe. (2023) pubmed
- 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. (2017) pubmed
- A fatal poisoning involving 25C-NBOMe. (2015) pubmed
- The high frequency oscillation in orbitofrontal cortex is susceptible to phenethylamine psychedelic 25C-NBOMe in male rats. (2023) pubmed
- 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and in vivo. (2019) pubmed